Intelligent Patient-Controlled Oral Liquid Medicine Dispenser and Deactivation System

Publication ID: 24-11857504_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Patient-Controlled Oral Liquid Medicine Dispenser and Deactivation System,” Published Technical Disclosure No. 24-11857504_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857504_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,504.

Summary of the Inventive Concept

A novel, synergistic system integrating AI, IoT, blockchain, and machine learning to enhance patient-controlled liquid oral medicine dispensing and deactivation, ensuring medication adherence, secure data storage, and optimized dosing regimens.

Background and Problem Solved

The original patient-controlled oral liquid medicine dispenser and deactivation system addressed the limitations of invasive medication administration. However, it lacked the capabilities to track medication adherence, ensure secure data storage, and optimize dosing regimens. The new inventive concept solves these problems by integrating distinct technologies to create a more powerful and effective system.

Detailed Description of the Inventive Concept

The system comprises a patient-controlled oral liquid medicine dispenser and deactivation system with a dosing container, spillway, sealed waste receptacle, and suction apparatus. The innovative aspect lies in the integration of an AI-powered monitoring module to track medication adherence and send alerts for non-compliance, a blockchain-based secure data storage and sharing platform, IoT-enabled sensors to monitor and control the dispensing process, and machine learning algorithms to predict optimal dosing regimens. The system can be further integrated with wearable devices and cloud-based analytics platforms to enhance its functionality.

Novelty and Inventive Step

The novelty of the new claims lies in the synergistic integration of AI, IoT, blockchain, and machine learning technologies with the patient-controlled oral liquid medicine dispenser and deactivation system, providing a more comprehensive and effective solution for medication management. The inventive step is the combination of these distinct technologies to create a new, more powerful system that addresses the limitations of the original patent.

Alternative Embodiments and Variations

Alternative embodiments may include varying the type of AI algorithm used, incorporating additional sensors or monitoring devices, or integrating the system with other healthcare technologies. Variations may include adapting the system for different types of medications, patient populations, or care settings.

Potential Commercial Applications and Market

The intelligent patient-controlled oral liquid medicine dispenser and deactivation system has significant commercial potential in the healthcare industry, particularly in the areas of medication management, patient adherence, and personalized medicine. Target markets may include hospitals, clinics, pharmaceutical companies, and healthcare technology providers.

CPC Classifications

SectionClassGroup
A A61 A61J7/0053
A A61 A61J1/22
G G16 G16H20/13
A A61 A61J2200/30
A A61 A61J2200/70

Original Patent Information

Patent NumberUS 11,857,504
TitlePatient-controlled liquid oral medicine dispenser and deactivation system
Assignee(s)Yale University